Jia Luo
Rare Disease / Clinical Research
Dana-Farber - Harvard Cancer Center LAO
QC-verified· March 2026 PI on 2 trials 207 publications
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
Clinical trials (2)
Verify independently
Other specialists for NUT midline carcinoma
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Jochen H Lorch, MD, M.DNorthwestern UniversityIL
- Judy Chiao, MDEpigenetix, Inc.
- Dawn Pinchasik, MD, M.DTScan Therapeutics, Inc.PA
- Pasi A Janne, MD, PhD, MD PHDDana-Farber Cancer InstituteMA
- Gianni Bisogno, MDAzienda Ospedale Università Padova - Italy
- Boehringer IngelheimThe Institute for Liver Health II DBA Arizona Clinical TrialsArizona
- Geoffrey I ShapiroDana-Farber - Harvard Cancer Center LAO